Tiina Kasanen

Helsinki, 00290, Finland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

Multimodal immunopharmacologic screens identify drugs rewiring the cancer-immune interface.

Journal: bioRxiv : the preprint server for biology
Published: April 27, 2026

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Journal: Cancer immunology research
Published: February 04, 2026

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

Single-cell analysis of aplastic anemia reveals a convergence of NK and NK-like CD8+ T cells with a disease-associated TCR signature.

Journal: Science translational medicine
Published: February 26, 2025

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Journal: Blood
Published: May 17, 2024

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Journal: Leukemia
Published: March 31, 2023

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia.

Journal: Leukemia
Published: May 13, 2022

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

Journal: The Journal of clinical investigation
Published: July 06, 2021

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia.

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia.

Journal: Nature communications
Published: June 14, 2021

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line.

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line.

Journal: Oncoimmunology
Published: January 03, 2019

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Journal: Leukemia
Published: August 24, 2016

Identification of three oligo-/polysaccharide-specific ligases in Yersinia enterocolitica.

Identification of three oligo-/polysaccharide-specific ligases in Yersinia enterocolitica.

Journal: Molecular microbiology
Published: November 08, 2011
Showing 1-11 of 11

Last Updated: 09/26/2026